Repositioning antipsychotic fluphenazine hydrochloride for treating triple negative breast cancer with brain metastases and lung metastases.
Fuyan Xu(Sichuan University), Luoting Yu(State Key Laboratory of Biotherapy), Yuquan Wei(Sichuan University), Min Luo(Sichuan University), Cuiting Peng(Sichuan University), Xi Yu(Peking University), Qiang Xue(Sichuan University), Yong Xia, Yufei Yang(Shanxi University), Jinrui Jiang(Sichuan University), Zhanzhan Feng(Sichuan University), Wentao Lin(The Affiliated Yongchuan Hospital of Chongqing Medical University)
PubMed
January 1, 2019
Cited by 45
Related Papers
SARS-CoV-2 M <sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse model
|Science|2021|449
Redox homeostasis: the linchpin in stem cell self-renewal and differentiation
|Cell Death and Disease|2013|287
A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications
|Frontiers in Cell and Developmental Biology|2021|144
The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model
|PLoS ONE|2014|131
Antitumor and Adjuvant Activity of λ-carrageenan by Stimulating Immune Response in Cancer Immunotherapy
|Scientific Reports|2015|116